Review of Small Cell Carcinomas of the Prostate
Authors:
Open Access
- 4 August 2011
- journal article
- review article
- Published by Hindawi Limited in Prostate Cancer
- Vol. 2011, 1-5
Abstract
Small cell carcinoma of the prostate is a rare neoplasm, with only a few series hitherto reported. A little less than half of the cases are associated with conventional acinar adenocarcinoma, which are usually high grade. Although consensus has not been reached, the majority of patients with small cell neuroendocrine carcinoma of the prostate have advanced disease at diagnosis and disproportionally low PSA levels compared to patients with conventional acinar adenocarcinoma. Treatment consists mainly of chemotherapy associated with surgery. Radiation therapy is reserved for selected cases. This study reviews the most up-to-date information on small cell carcinomas of the prostate.Keywords
This publication has 51 references indexed in Scilit:
- PC3 is a cell line characteristic of prostatic small cell carcinomaThe Prostate, 2011
- Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostateInternational Journal of Clinical Oncology, 2011
- ERG gene rearrangements are common in prostatic small cell carcinomasLaboratory Investigation, 2011
- Distribution of High Chromogranin A Serum Levels in Patients with Nonmetastatic and Metastatic Prostate AdenocarcinomaUrologia Internationalis, 2009
- Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostateThe Prostate, 2009
- Small-cell prostate carcinoma: A retrospective analysis of five newly reported casesIndian Journal of Urology, 2009
- Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications—A Retrospective Study of 30 Patients From the Rare Cancer NetworkThe American Journal of the Medical Sciences, 2008
- Primary carcinoid tumour of the prostatePathology, 2005
- CHROMOGRANIN A CONCENTRATION AS A SERUM MARKER TO PREDICT PROGNOSIS AFTER ENDOCRINE THERAPY FOR PROSTATE CANCERJournal of Urology, 2002
- The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primaryJournal of Cancer Research and Clinical Oncology, 1996